The influence of nonspecific immunomodulation with Thymomodulin (a calf thymic extract with immunomodulatory activity) and hydrocortisone on the course and location of Cryptospori dium parvum infection in neonatal BALB/c mice (infected with 106 or 105 oocysts on day 7 of life) was studied using scanning electron microscopy of the inner surface of different parts of intes tine. Daily peroral treatment of suckling mice with 20 mg/kg/day of Thymomodulin for 5 days before inoculation resulted in an earlier peak and earlier termination of cryptosporidial infection when compared with control infected mice. On the other hand, peroral administration of 25 mg/kg of hydrocortisone every second day led to the persistence of cryptosporidial infection in the ileum of immunosuppressed mice until the end of observation (day 15 post infection), whereas only transient infection was observed in the intestine of control infected mice. The location of infection was also altered in hydrocortisone-treated mice-the severe infec tion was observed in more proximal parts of the intestine (ante rior and middle jejunum), whereas no Cryptosporidia were found in these parts of the intestine in nontreated infected mice. Cryptosporidiosis (Cryptosporidium parvum) is a proto zoan infection frequently associated with certain immunodeficient states (Lockwood and Weber, 1989; Mead et al. , 1986) . Both cell-mediated and humoral immune responses are elicited by Cryptosporidium, but functional cellmediated immunity is necessary for the recovery from infec tion (Current and Garcia, 1991) . The strong thymicdependence of anti-cryptosporidial resistance was demons trated in experiments on athymic animals, persistent infec tion being observed in adult athymic nude mice (Heine et al., 1984; Ungar et al., 1990; Mead et al., 1991b) and rats (Gardner et al., 1991) , whereas immunocompetent ani mals developed only transient asymptotic infection (Enri quez and Sterling, 1991) . Persistent infection similar to that in athymic mice was reported in neonatal suckling BALB/c mice treated with monoclonal antibody that eliminated CD4+ T-lymphocytes (Ungar et al., 1990 (Ungar et al., , 1991 . On the other hand, the course of infection was not altered in Bcell-depleted mice (treated with rabbit anti-mouse IgM anti bodies, Taghi-Kilani et al., 1990) , nor in mast-cell-deficient W/Wv mice (Harp and Moon, 1991) .
The most widely used laboratory animal model for cryptosporidiosis involves infection of neonatal suckling mice within first the 2 weeks of life, which leads to the development of a self-limited infection (Current and Garcia, 1991 ; Novak and Sterling, 1991) . Due to its relative immunoincompetence the neonatal mouse (Murgita and Wigzell, 1981 ) represents a suitable model for a study of the impact of immunomodulation on resistance to cryptosporidial infection. In this study we examined the possibi lity of influencing the course and location of cryptosporidial infection in neonatal BALB/c mice by administration of Thymomodulin (a partially purified calf thymic extract, Cazzola et al., 1987) or hydrocortisone-nonspecific immunomodulators acting preferentially on T-cell immunity (Renoux and Renoux, 1980; Bach, 1987 ; Oates et al., 1989) .
MATERIALS AND METHODS

Mice
The neonatal BALB/c mice originated from pregnant SPF mice (Velaz, Prague). Each litter of neonatal mice was kept individually and remained with their dam during the whole experiment.
Parasite
Cryptosporidium parvum oocysts were isolated from the feces of a naturally infected calf by filtration through a metal sieve and centrifugation on a sucrose density gradient, sterilised by incu bation with commercial bleach, washed 5 times with phosphatebuffered-saline (PBS) and stored (for less than 2 months) in 2.5 % potassium dichromate at 4° C until used. Immediately before admi nistration, the oocysts were washed several times with sterile PBS to remove potassium dichromate and counted using a hemocytometer. All experimental mice were inoculated with 0.1 ml inoculum by gastric gavage using a tuberculin syringe and a 22-gauge fee ding needle.
Immunomodulators and Experimental Design
Experiment 1: Neonatal mice (both sexes) of the same age (born within 24 hours) were divided into three groups. The TM-group (25 animals) were treated perorally with 20 mg/kg/day of Thymo modulin (« Leucotrofina 50 » kindly provided by Dr. Cazzola, ELLEM Industria farmaceutica Milano) starting from day 2 of life up to the day preceding inoculation. The HC-group (25 animals) were treated perorally with 25 mg/kg/dose of hydrocortisone (SoluCortef, Upjohn) every second day from day 2 of life until day 13 post infection (DPI 13). The nontreated infected mice (25 animals) served as control group. All mice were inoculated with 107 oocysts of C. parvum on day 7 of life (DPI 0). Experiment 2: The experimental mice were divided into three groups and treated perorally with 25 mg/kg/dose of hydrocortisone (SoluCortef, Upjohn) every second day starting from day 2 of life up to the end of experiment (group HC-1, 20 animals) or up to DPI 5 (group HC-2, 20 animals) or up to the day preceding inoculation (group HC-3, 20 animals). The nontreated infected mice (20 animals) served as a control group. All the mice were inocu lated on day 7 of life with 107 oocysts of C. parvum.
Evaluation of Intensity of Infection
Fecal samples were collected directly from the rectum from 5 mice of each experimental group every day throughout experiments in order to evaluate the prepatent and patent periods of infection. The fecal pellets were smeared onto microscopic slides and stained with aniline-carbol-methyl-violet (Miláček and Vítovec, 1985) to detect oocysts. Every second day (starting from DPI 1 in experi ment 1 or DPI 3 in experiment 2) 3 mice from each group were killed by cervical dislocation and 3 (ileum, cecum and colon, in experiment 1) or 5 (anterior and middle jejunum, ileum, cecum and colon, in experiment 2) 1.0-1.5 cm-segments of intestine were removed, opened longitudinally and fixed in phosphate-buffered 4 % paraformaldehyde (pH 7.4). The fixed intestinal segments were dehydrated using ascending ethanol gradients. Specimens were fur ther desiccated by critical point drying and then coated with goldpalladium. After mounting on aluminium stubs, the intestinal mucosa was examined with the scanning electron microscope (SEM) TESLA BS-300, using an accelerating voltage of 19 kV. All speci mens were routinely examined at intermediate (500x), and high (3,500x, 5,000x) magnifications. Other levels of magnification were used to highlight a particular finding.
On the basis of the SEM findings the degree of infection was classified as follow:
degree 0: no Cryptosporidia found on the mucosal surface; degree 1: moderate infection, sporadic Cryptosporidia distributed on the surface of villi or in crypts, representing less than 100
Cryptosporidia per jejunal or ileal villus (10 villi examined at random), and less than 100 cryptospordia seen in any of 10 cecal or colonic SEM fields at magnification 500x; degree 2: medium infection, regularly disseminated Cryptosporidia on the surface of villi and in crypts representing from 100 to 300 Cryptosporidia per jejunal or ileal villus (10 villi examined at random), or from 100 to 300 Cryptosporidia seen in any of 10 cecal or colonic SEM field at magnification 500x; degree 3: severe infection, most of the epithelial surface covered by Cryptosporidia representing more than 300 Cryptosporidia per jejunal or ileal villus (10 villi examined at random), or more than 300 Cryptosporidia seen in any of 10 cecal or colonic SEM field at magnification 500x, but less than 100 Cryptosporidia per jejunal or ileal SEM field at magnification 5,000x, or less than 100 Cryptos poridia per cecal or colonic field at magnification 3,500x; degree 4: massive infection, almost the whole epithelium covered by Cryptosporidia representing more than 100 Cryptosporidia per jejunal or ileal SEM field at magnification 5,000x (10 SEM field examined), or more than 100 Cryptosporidia seen in any of 10 cecal or colonic SEM field at magnification 3,500x.
Each point in the graphs represents the mean degree of infec tion observed in 3 mice. This methodological approach does not allow statistical analysis of the data, but has a great advantage in the complex evaluation of the intensity of cryptosporidial infec tion in that part of intestine examined.
RESULTS
In experiment 1, oocysts of C. parvum in the smears of rectal content from the control infected mice as well as from the Thymomodulin-treated mice were first detected on DPI 3 and the shedding of oocysts peaked between DPI 5 and 7. Cryptosporidial oocysts were observed until DPI 12 in smears from nontreated infected mice, indica ting a patent period of 9 days. The patent period in the Thymomodulin-treated mice was shorter (7 days) and the shedding of cryptosporidial oocysts ceased on DPI 10. In both experiments, the hydrocortisone-treated mice began to shed oocysts on DPI 5 or DPI 6 and shedding persisted until the end of our observation (DPI 15 in experiment 1 and DPI 13 in experiment 2). jejunum), whereas no parasites were detected in these parts of the intestine in nontreated infected mice (Figs. 2a, 2b) . Infection persisted in the middle jejunum and ileum of mice treated with hydrocortisone throughout the whole experiment (HC-1 group), however no Cryptosporidia or only moderate infection were observed on DPI 13 in mice treated until DPI 5 (HC-2 group) or until the day prece ding inoculation (HC-3 group, Figs. 2a, 2b, 2c) . The inten sity of infection in the large intestine (cecum and colon) of hydrocortisone-treated mice was much lower than in nontreated control mice (Figs. 2d, 2e) .
DISCUSSION
The present results clearly indicated that (i) the prophy lactic administration of Thymomodulin resulted in the ear lier recovery of neonatal BALB/c mice from C. parvum infection, compared with nontreated infected mice;
The influence of the administration of Thymomodulin and hydrocortisone on the course of cryptosporidial infec tion in neonatal BALB/c mice (experiment 1) is summa rised on Figure 1 . Treatment with Thymomodulin for 5 days before inoculation resulted in the earlier peak and earlier termination of infection (Figs. 3A, 3C ). On the other hand, infection persisted in hydrocortisone-treated mice until the end of observation (DPI 15), whereas no Cryptosporidia were observed in the ileum of untreated infected mice at this time. The small developmental stages of C. parvum together with the large mature stages were observed on the inner surface of ileal mucosa of hydrocortisone-treated mice until the end of experiment 1 (Fig. 3E) . This influence of hydrocortisone on the course of infection was confirmed with a smaller inoculum of Cryptosporidia in experiment 2 (Fig. 2c , group HC-1/ Moreover, the location of cryptos poridial infection was altered in all of the treated mice. A medium to severe degree of infection was observed in proximal parts of the intestine (anterior and middle (ii) immunosuppression by hydrocortisone resulted in the persistence of cryptosporidial infection in suckling mice; (Hi) cryptosporidial infection was restricted to the anterior and middle jejunum of hydrocortisone-treated mice, and shifted to the large intestine after treatment ceased. Consi dering that the immune status of the host appears to be the major factor determining the severity and duration of cryptosporidial infection and that effective chemotherapy of cryptosporidiosis is not yet available, immunological intervention seems to be a hopeful approach to control. Transfer of specific resistance against C. parvum infection has been already discussed in literature (especially the pos sible roles of humoral and cellular factors in such a transfer). Moon et al. (1988) showed that immune mice were unable to transfer protective immunity to their offs pring, and Harp and Whitmire (1991) failed to transfer resistance to neonatal mice by the intraperitoneal injection of spleen or mesenteric lymph node cells from immune adult mice. On the other hand, Ungar et al. (1990) demons trated that these cells were able to transfer resistance to infected athymic nude mice. Controversial results have also been reported on the protective efficacy of an immune (spe cific) bovine transfer factor (dialyzable leukocyte extract, DLE). Fayer et al. (1987) showed that such a preparation failed to protect neonatal calves against cryptosporidiosis, however McMeeking et al. (1990) described therapeutic effect of DLE in AIDS patients suffering from cryptospo ridial diarrhoea. There have been many attempts to use different antibody-containing preparations, but the efficacy of these preparations remains questionable (Current and Garcia, 1991) . Oral administration of colostrum from natu rally infected cows did not alter the course of cryptospori dial infection in an AIDS patient (Saxon et al., 1987) , however hyperimmune colostrum showed a therapeutic effect in immunodeficient patients (Tzipori et al., 1986) and protective effect in calves (Fayer et al., 1989a) and neonatal mice (Arrowood et al., 1989; Fayer et al., 1989b) . A similar immunotherapeutic effect on cryptosporidiosis in neonatal mice was reported for the immunoglobulin frac tion of hyperimmune colostrum (Fayer et al., 1990) or hyperimmune serum (Riggs and Perryman, 1987) . Admi nistration of a monoclonal anticryptosporidial antibody significantly reduced the intensity of infection in neonatal mice (Arrowood et al., 1987) and athymic nude mice (Bjorneby, 1991), but not in SCID foals (Perryman and Bjorneby, 1991) . Considering these problems with development of specific immunotherapy then it is possible that non-specific immunomodulation could play an important role in the control of cryptosporidiosis, especially in immunocompromised hosts. The complete resolution of intestinal cryptospori diosis after discontinuation of immunosuppressive chemo therapy, allowing restoration of immune function, was reported in several patients (Miller et al., 1983; Stine et al., 1985) . Moreover, Mead et al. (1991) demonstrated com plete eradication of Cryptosporidia in SCID mice reconsti tuted with murine thymocytes, spleen or mesenteric lymph node cells from naive congenic donors. Indirect evidence of a possible role for non-specific immunomodulators in the therapy of cryptosporidiosis has been reported for recombinant interleukin-2 (Kern et al., 1985) . Given the key role of T-cell mediated immunity in resistance to C. parvum infection, we presumed that thymic factors, which facilitate the differentiation of T-lymphocytes (Bach, 1987; Oates et al., 1989) , might be a promising group of immunomodulators for the control of cryptosporidiosis, especially in immunocompromised hosts. Protective effect of thymic preparations in experimental parasitic infection was firstly reported by ourselves (Heřmánek, 1991) . This study is the first report of a beneficial influence of thymic extract on cryptosporidiosis in neonatal mice.
Peroral prophylactic administration of Thymomodulin resulted in the earlier recovery of neonatal BALB/c mice from cryptosporidial infection. The beneficial effect of Thymomodulin may reflect the faster maturation of immu nocompetent cells in neonatal mice, because in vitro res ponsiveness of splenocytes to the T-celll mitogen ConA in the infected Thymomodulin-treated mice also increased more rapidly then in nontreated mice (data not shown). This suggestion is supported by the observation of Golds tein and Coworkers (1971) , that the administration of ano ther thymic preparation (thymosin) significantly accelerated the development of immunocompetence in neonatal mice. Our conclusions were also supported by the description of the enhancing activity of Thymostimulin in the chemo therapy of acute cryptosporidiosis in AIDS-patients (Bar baro et al., 1990) . Chronic cryptosporidiosis has been reported in immunosuppressed rats (Brasseur et al., 1988; Regh et al., 1987 Regh et al., , 1988 , hamsters (Rossi et al., 1990) , guinea pigs (Angus et al., 1985; Chrisp et al., 1990) , immu nosuppressed adult mice (Rasmussen and Healey, 1992) , athymic and T-cell subset depleted mice (Heine et al., 1984; Ungar et al., 1990 Ungar et al., , 1991 , germ-free adult mice , adult SCID mice (Mead et al., 1991) and retrovirally infected mice (Darban et al., 1991) . Hydrocortisoneimmunosupressed models for cryptosporidiosis have been characterized for rats and hamsters (Brasseur et al., 1988 ; Rossi et al., 1990) , however our study is the first attempt to characterise the course of cryptosporidial infection in neonatal mice immunossupressed with various regimens of hydrocortisone administration. SEM examination of the mucosal surface of treated mice showed that the infection persisted for at least for 15 days. Both small developmental stages of C. parvum as well as large mature stages were observed on the ileal mucosa of hydrocortisone-treated mice. We suppose that the presence of these small developmental stages in chronic infection reflects the autoinfective cha racter of cryptosporidial infection (Current and Garcia, 1991) .
The persistence of cryptosporidial infection in the ileum associated with lower intensity of infection in the cecum and colon of hydrocortisone-treated neonatal mice (experi ment 1) suggest that the location of infection is immunedependent and may therefore be influenced by non-specific immunosuppression. To confirm this hypothesis we analysed the course of infection in more proximal parts of the intes-tine and in different regimes of hydrocortisone adminis tration. The results (experiment 2) indicated that infection was found more proximally in hydrocortisone-treated mice, whereas no parasites were found in these parts of intestine in nontreated infected animals. In other immunocompro mised animal models of chronic cryptosporidiosis only Ungar et al. (1990) and Rasmussen and Healey (1992) have demonstrated Cryptosporidia in the anterior part of gas trointestinal tract. Ungar et al. (1990) observed Cryptospo ridia in the pyloric ring and duodenum of neonatally infected BALB/c mice treated with anti-CD4 monoclonal antibodies. Rasmussen and Healey (1992) found the grea test numbers of parasites in the jejunum, ileum, and colon, but Cryptosporidia were also localised in the gastric glands of the stomach and in the duodenum of adult mice treated with dexamethasone. In our study, a gradual shift of the infection to the more distal parts of the intestine was observed after cessation of hydrocortisone-treatment. It is possible that this shift represents the expulsion of Cryptos poridia following reconstitution of the impaired immune system. Similar clearance of Cryptosporidia was described by Rehg et al. (1987 after withdrawal of cyclophoshamide or dexamethasone treatment in immunosuppressed rats. Moreover, a complete resolution of intestinal cryptos poridiosis after discontinuation of immunosuppressive che motherapy, allowing restoration of immune function, has been reported in several patients (Miller et al., 1983 ; Stine et al., 1985) .
Further investigations of the influence of nonspecific immunomodulation on mechanisms controlling the resis tance to Cryptosporidium infection are in progress.
